Constitutive expression of the α4 integrin correlates with tumorigenicity and lymph node metastasis of the B16 murine melanoma

Neoplasia

Volumn 12, Issue 2, 2010, Pages 173-182

  Rebhun, Robert B ^a   Cheng, Hua ^b   Gershenwald, Jeffrey E ^c   Fan, Dominic ^c   Fidler, Isaiah J ^c   Langley, Robert R ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; CHEMOKINE RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN RECEPTOR 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CELL ADHESION; CELL INTERACTION; CONTROLLED STUDY; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; LYMPH NODE METASTASIS; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; ENDOTHELIUM CELL; EXPERIMENTAL MELANOMA; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL ADHESION; CELL LINE, TUMOR; ENDOTHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; INTEGRIN ALPHA4; LYMPHATIC METASTASIS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, NUDE; VASCULAR CELL ADHESION MOLECULE-1;

EID: 76749096264     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.91604     Document Type: Article

References (50)

1. Balch CM (1988). The role of elective lymph node dissection in melanoma: rationale, results, and controversies. J Clin Oncol 6, 163-172.
2. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A Jr, Kirkwood JM, et al. (2003). New TNM melanoma staging system: linking biology and natural history to clinical outcomes. Semin Surg Oncol 21, 43-52.
3. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A Jr, Kirkwood JM, et al. (2001). Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19, 3635-3648.
4. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, Urist M,McMasters KM, Ross MI, Kirkwood JM, et al. (2001). Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19, 3622-3634.
5. Callery C, Cochran AJ, Roe DJ, Rees W, Nathanson SD, Benedetti JK, Elashoff RM, and Morton DL (1982). Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes. Ann Surg 196, 69-75.
6. Rinderknecht M and Detmar M (2008). Tumor lymphangiogenesis and melanoma metastasis. J Cell Physiol 216, 347-354.
7. 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy. J Immunol 174, 1462-1471.
8. 2- microglobulin loss-of-function in melanoma cells. J Biol Chem 281, 18763-18773.
9. Johnson JP (1994). Cell adhesion molecules in the development and progression of malignant melanoma. Cancer Metastasis Rev 18, 345-357.
10. Nesbit M and Herlyn M (1994). Adhesion receptors in human melanoma progression. Invasion Metastasis 14, 131-146.
11. 3 subunit with tumor progression. Cancer Res 50, 6757-6764.
12. Schadendorf D, Gawlik C, Haney U, Ostmeier H, Suter L, and Czarnetzki BM (1993). Tumour progression and metastatic behaviour in vivo correlates with integrin expression on melanocytic tumours. J Pathol 170, 429-434.
13. Schadendorf D, Heidel J, Gawlik C, Suter L, and Czarnetzki BM (1995). Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels. J Natl Cancer Inst 87, 366-371.
14. 1 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances migration of human melanoma cells across activated endothelial cell layers. J Cell Physiol 212, 368-374.
15. Martin-Padura I, Mortarini R, Lauri D, Bernasconi S, Sanchez-Madrid F, Parmiani G, Mantovani A, Anichini A, and Dejana E (1991). Heterogeneity in human melanoma cell adhesion to cytokine activated endothelial cells correlates with VLA-4 expression. Cancer Res 51, 2239-2241.
16. Garofalo A, Chirivi RG, Foglieni C, Pigott R, Mortarini R, Martin-Padura I, Anichini A, Gearing AJ, Sanchez-Madrid F, Dejana E, et al. (1995). Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastases. Cancer Res 55, 414-419.
17. Langley RR, Carlisle R, Ma L, Specian RD, Gerritsen ME, and Granger DN (2001). Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma. Microcirculation 8, 335-345.
18. Rebhun RB, Langley RR, Yokoi K, Fan D, Gershenwald JE, and Fidler IJ (2006). Targeting receptor tyrosine kinase on lymphatic endothelial cells for the therapy of colon cancer lymph node metastasis. Neoplasia 8, 747-757.
19. Langley RR, Ramirez KM, Tsan RZ, Van Arsdall M, Nilsson MB, and Fidler IJ (2003). Tissue-specific microvascular endothelial cell lines from H-2K(b)-tsA58 mice for studies of angiogenesis and metastasis. Cancer Res 63, 2971-2976.
20. Garlanda C and Dejana E (1997). Heterogeneity of endothelial cells. Specific markers. Arterioscler Thromb Vasc Biol 17, 1193-1202.
21. Gerritsen ME (1987). Functional heterogeneity of vascular endothelial cells. Biochem Pharmacol 36, 2701-2711.
22. Rebhun RB, Lazar AJ, Fidler IJ, and Gershenwald JE (2008). Impact of sentinel lymphadenectomy on survival in a murine model of melanoma. Clin Exp Metastasis 25, 191-199.
23. Sasaki T, Nakamura T, Rebhun RB, Cheng H, Hale KS, Tsan RZ, Fidler IJ, and Langley RR (2008). Modification of the primary tumor microenvironment by transforming growth factor α-epidermal growth factor receptor signaling promotes metastasis in an orthotopic colon cancer model. Am J Pathol 173, 205-216.
24. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, and Mitchell JB (1987). Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47, 936-942.
25. Baluk P and McDonald DM (2008). Markers for microscopic imaging of lymphangiogenesis and angiogenesis. Ann N Y Acad Sci 1131, 1-12.
26. Wang HH, McIntosh AR, Hasinoff BB, Rector ES, Ahmed N, Nance DM, and Orr FW (2000). B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: a natural hepatic defense against metastasis. Cancer Res 60, 5862-5869.
27. Kakinuma T and Hwang ST (2006). Chemokines, chemokine receptors, and cancer metastasis. J Leuk Biol 79, 639-651.
28. Langley RR and Fidler IJ (2007). Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr Rev 28, 297-321.
29. Alvarez D, Vollmann EH, and von Andrian UH (2008). Mechanisms and consequences of dendritic cell migration. Immunity 29, 325-342.
30. Johnson LA and Jackson DG (2008). Cell traffic and the lymphatic endothelium. Ann N Y Acad Sci 1131, 119-133.
31. Nathanson SD, Haas GP, Mead MJ, and Lee M (1986). Spontaneous regional lymph node metastases of three variants of the B16 melanoma: relationship to primary tumor size and pulmonary metastases. J Surg Oncol 33, 41-45.
32. Bevilacqua MP (1993). Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 11, 767-804.
33. Ley K and Huo Y (2001). VCAM-1 is critical in atherosclerosis. J Clin Invest 107, 1209-1210.
34. Soriano A, Salas A, Sans M, Gironella M, Elena M, Anderson DC, Pique JM, and Panes J (2000). VCAM-1, but not ICAM-1 or MAdCAM-1, immunoblockade ameliorates DSS-induced colitis in mice. Lab Invest 80, 1541-1551.
35. Carter RA and Wicks IP (2001). Vascular cell adhesion molecule 1 (CD106): a multifaceted regulator of joint inflammation. Arthritis Rheum 44, 985-994.
36. Rice GE and Bevilacqua MP (1989). An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 246, 1303-1306.
37. Nelson GM, Padera TP, Garkavtsev I, Shioda T, and Jain RK (2007). Differential gene expression of primary cultured lymphatic and blood vascular endothelial cells. Neoplasia 9, 1038-1045.
38. Saban MR, Memet S, Jackson DG, Ash J, Roig AA, Israel A, and Saban R (2004). Visualization of lymphatic vessels through NF-κB activity. Blood 104, 3228-3230.
39. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, and Maniatis T (1995). Transcriptional regulation of endothelial cell adhesion molecules: NF-κ B and cytokine-inducible enhancers. FASEB J 9, 899-909.
40. 1 on melanoma cells can inhibit the invasive stage of metastasis formation. Cell 77, 335-347.
41. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, et al. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50-56.
42. Murphy WJ, Tian ZG, Asai O, Funakoshi S, Rotter P, Henry M, Strieter RM, Kunkel SL, Longo DL, and Taub DD (1996). Chemokines and T lymphocyte activation: II. Facilitation of human T cell trafficking in severe combined immunodeficiency mice. J Immunol 156, 2104-2111.
43. Forster R, Davalos-Misslitz AC, and Rot A (2008). CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 8, 362-371.
44. 4 integrin affinity for vascular cell adhesion molecule 1 which mediates arrest: an early step in the process of emigration. J Exp Med 193, 1149-1158.
45. Wiley HE, Gonzalez EB, Maki W, Wu M, and Hwang ST (2001). Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J Natl Cancer Inst 93, 1638-1643.
46. Uchida D, Begum NM, Tomizuka Y, Bando T, Almofti A, Yoshida H, and SatoM (2004). Acquisition of lymph node, but not distant metastatic potentials, by the overexpression of CXCR4 in human oral squamous cell carcinoma. Lab Invest 84, 1538-1546.
47. Kawada K, Sonoshita M, Sakashita H, Takabayashi A, Yamaoka Y, Manabe T, Inaba K, Minato N, Oshima M, and Taketo MM (2004). Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes. Can Res 64, 4010-4017.
48. 1 integrin in the coordination of avian truncal neural crest cell adhesion, migration, and survival. Dev Dyn 222, 127-140.
49. 1 function is required for cell survival in developing retina. Dev Biol 276, 416-430.
50. 1 integrins. Leukemia 19, 57-63.